Personalis, Inc. (PSNL) Stock Forecast

Personalis, Inc. (PSNL) Hit a 52 Week High, Can the Run Continue?

1y ago, source: Nasdaq

Shares of Personalis (PSNL) have been strong performers lately, with the stock up 167.7% over the past month. The stock hit a new 52-week high of $4.58 in the previous session. Personalis has ...

Personalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call Transcript

on MSN ago, source: Insider Monkey on MSN

Q2 2025 Earnings Call Transcript August 5, 2025 Personalis, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.25. Operator: Ladies and gentlemen, greetings, and welcome ...

Personalis Reports Second Quarter 2025 Financial Results

12d ago, source: Yahoo Finance

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the second quarter ended June 30, 2025, and recent accomplishments of its "W ...

Personalis, Inc. (NASDAQ:PSNL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

10d ago, source: Yahoo Finance

There's been a notable change in appetite for Personalis, Inc. (NASDAQ:PSNL) shares in the week since its quarterly report, with the stock down 17% to US$4.55. It wasn't the greatest result, with ...

Buy Rating Upheld for Personalis Inc. with Increased Price Target Amid ...

1y ago, source: Business Insider

Personalis, Inc. provides genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.

Personalis: Market-Leading Immuno-Oncology Platform Drives Long-Term ...

4y ago, source: Seeking Alpha

Personalis, Inc. (NASDAQ: NASDAQ: PSNL) is a global cancer genomics company offering genomic sequencing and data analytics solutions for comprehensive molecular data analysis for patient-specific ...

Personalis, Inc. to Present at Biomarkers Week Online 2021

4y ago, source: Business Wire

Personalis is a co-sponsor of Biomarkers Week and will have representatives available to answer questions about the company’s cancer immunogenomics capabilities. About Personalis, Inc.

Personalis Expands Tempus Strategic Collaboration to Bring Ultra ...

1mon ago, source: Seeking Alpha

Collaboration extension through 2029 accelerates access to MRD technology across four major cancer types Colorectal cancer affects over 150,000 new patients in the U.S. annually, with many ...

Personalis Named to Inc.'s 2021 Best-Led Companies List

3y ago, source: Business Wire

MENLO PARK, Calif.-- (BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that it has been named to Inc. ’s inaugural 2021 Best-Led ...

What Type Of Shareholders Own The Most Number of Personalis, Inc ...

3y ago, source: Nasdaq

October 26, 2021 — 11:30 am EDT Written by Simply Wall St for Simply Wall St -> A look at the shareholders of Personalis, Inc. (NASDAQ:PSNL) can tell us which group is most powerful.

Personalis Expands Tempus Strategic Collaboration to Bring Ultra ...

1mon ago, source: Morningstar

Personalis, Inc. (Nasdaq: PSNL) today announced an expansion and extension of its strategic collaboration with Tempus AI, Inc. (Nasdaq: TEM), adding a new indication, colorectal cancer (CRC), to ...

Company	Ticker	90 Days Forecast	Market Cap. (USD M)	P/E	P/B
Aclarion, Inc.	ACON	Predict	2.93	-0.03	1.17
Aclarion, Inc.	ACONW	Predict	0.45	None	0.18
Advanced Biomed Inc.	ADVB	Predict	9.54	None	2.31
AMERICAN SHARED HOSPITAL SERVICES	AMS	Predict	16.38	5.20	0.66
BIODESIX INC	BDSX	Predict	58.05	-3.00	51.01
BioNexus Gene Lab Corp	BGLC	Predict	76.36	None	9.83
Burning Rock Biotech Ltd	BNR	Predict	0.00	None	0.00
Caris Life Sciences, Inc.	CAI	Predict	10259.80	7.55	22.65
CareDx, Inc.	CDNA	Predict	648.61	12.55	1.98
Celcuity Inc.	CELC	Predict	2245.60	-4.47	50.60
CASTLE BIOSCIENCES INC	CSTL	Predict	582.23	-2110.50	1.28
QUEST DIAGNOSTICS INC	DGX	Predict	20305.54	21.37	2.81
EXACT SCIENCES CORP	EXAS	Predict	8628.46	-343.62	3.49
Fulgent Genetics, Inc.	FLGT	Predict	649.52	516.76	0.58
Fortrea Holdings Inc.	FTRE	Predict	730.03	-6.75	1.24
Guardant Health, Inc.	GH	Predict	7329.26	-8.86	-22.95
GRAIL, Inc.	GRAL	Predict	1171.55	None	0.51
LABCORP HOLDINGS INC.	LH	Predict	22783.78	29.84	2.69
Natera, Inc.	NTRA	Predict	22294.13	-74.23	17.89
PSYCHEMEDICS CORP	PMD	Predict	11.79	-5.67	2.16
PSYCHEMEDICS CORP	PMDI	Predict	13.99	None	2.73
Personalis, Inc.	PSNL	Predict	407.79	-2.25	2.14
RadNet, Inc.	RDNT	Predict	6431.66	462.82	6.90
Renalytix plc	RENXF	Predict	9.96	None	None
Renalytix plc	RNLXY	Predict	23.23	None	None
SERA PROGNOSTICS, INC.	SERA	Predict	102.46	-8.99	1.16
VERACYTE, INC.	VCYT	Predict	2425.92	92.12	1.99
EXAGEN INC.	XGN	Predict	208.77	-5.36	9.93